Synopsis: Zydus Wellness Ltd delivered a strong performance in Q4 FY26, supported by healthy revenue growth, improved operational efficiency, and robust demand across its wellness and nutrition portfolio. The company reported strong sequential growth in profitability during the quarter. Alongside the earnings announcement, the board recommended a final dividend of Rs. 1.20 per equity share for FY26.
Zydus Wellness Ltd is one of India’s leading consumer wellness companies, offering health-focused products across categories such as sugar substitutes, nutrition drinks, skincare, and personal wellness solutions. The company owns popular brands including Sugar Free, Nutralite, Everyuth, and Glucon-D.
With increasing health awareness, premiumization trends, and rising consumption in urban as well as rural markets, Zydus Wellness continues to strengthen its position in India’s fast-growing wellness and FMCG sector.
Zydus Wellness currently has a market capitalization of around Rs. 15,841 crore, with the stock trading near Rs. 493 down by 1.80% compared to its previous close of Rs. 502. The company has a stock P/E ratio of 65.9 and a book value of Rs. 179 per share.
The company maintains stable return ratios with ROCE of 6.16 percent and ROE of 6.02 percent. Investors continue to track the stock due to its strong wellness portfolio, expanding distribution network, and improving consumer demand trends.
Zydus Wellness reported revenue from operations of Rs. 1,476.1 crore in Q4 FY26, compared to Rs. 963.3 crore in Q3 FY26, reflecting a sharp sequential growth of nearly 53 percent. On a year-on-year basis, revenue increased around 62 percent from Rs. 910.6 crore reported in Q4 FY25.
Total income stood at Rs. 1,485.9 crore during the quarter, while total expenses came in at Rs. 1,308.6 crore. Operating performance improved significantly during the quarter due to stronger product demand and better scale efficiencies.
Profit before tax came at Rs. 177.3 crore in Q4 FY26, compared to a loss before tax of Rs. 41.5 crore in Q3 FY26. On a YoY basis, PBT remained largely stable against Rs. 173.4 crore reported in Q4 FY25.
Net profit for the quarter stood at Rs. 162 crore, registering a sharp turnaround from a loss of Rs. 39.9 crore in Q3 FY26. However, on a yearly basis, profit declined slightly from Rs. 171.9 crore reported in Q4 FY25. Earnings per share stood at Rs. 5.09 for the quarter.
For the full financial year FY26, the company reported revenue from operations of Rs. 3,940 crore, compared to Rs. 2,691.2 crore in FY25. Annual net profit came at Rs. 197.2 crore during FY26.
The Board of Directors recommended a final dividend of Rs. 1.20 per equity share having a face value of Rs. 2 each for FY26. The dividend recommendation is subject to shareholder approval at the upcoming Annual General Meeting scheduled for August 4, 2026.
Industry Outlook
India’s FMCG and wellness sector continues to witness strong long-term growth driven by rising health awareness, premium consumption, and expanding rural demand. India’s food processing market reached US$354.5 billion in FY24 and is expected to touch US$535 billion by FY26, creating strong growth opportunities for consumer wellness companies.
The healthy snack market in India was valued at US$3.13 billion in 2025 and is projected to reach US$4.77 billion by 2034. Increasing quick-commerce penetration, premiumization, and government support for food processing and rural consumption are expected to further support the sector’s growth trajectory.
Zydus Wellness delivered a strong Q4 FY26 performance with robust revenue growth and a sharp improvement in profitability on a sequential basis. The company also rewarded shareholders with a final dividend announcement, reflecting management confidence in long-term business prospects.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Zydus Wellness Reports 62% QoQ Profit Surge in Q4 FY26; Announces 60% Final Dividend appeared first on Trade Brains.